Chronic kidney disease common in the United States

November 06, 2007

There is a high prevalence of chronic kidney disease in the United States, which has risen over the past decade, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. The study found that the overall prevalence of chronic kidney disease increased from 10 percent of the population during a period from 1988-1994 to 13 percent from 1999-2004. The researchers conclude that the increase in chronic kidney disease is partly due to the rise in number of Americans with diabetes and hypertension and the aging of the population. The study is published in the November 7, 2007, edition of JAMA.

Chronic kidney disease increases the risk for complications from medications cleared by the kidney, hypertension, anemia, bone disease, death from cardiovascular disease, and ultimately kidney failure, which requires treatment with kidney transplantation or dialysis.

"Our study demonstrates chronic kidney disease in the United States is more common than previously appreciated. However, less than 1 in 10 individuals with kidney disease are aware they have a problem," said Josef Coresh, MD, PhD, lead author of the study and professor in the Departments of Epidemiology and Medicine at Johns Hopkins University. "The medical community is starting to realize that chronic kidney disease is a serious concern, similar to the increased awareness of hypertension in the 1970s and diabetes in the 1990s."

Analyzing data from over 28,000 participants in the National Health and Nutrition Examination Surveys (NHANES) for 1988-1994 and 1999-2004, the research team measured the prevalence of chronic kidney disease stages 1-4. According to the results, the number of people with chronic kidney disease stages 1 and 2, those with increased protein in the urine but unimpaired kidney filtration, increased slightly from 4.4 percent during 1988-1994 to 5.0 percent during 1999-2004. Larger increases were seen in the prevalence of stages 3 and 4 kidney disease, which indicate impaired kidney function called glomerular filtration rate (GFR). A GFR less than 60 equals approximately half the kidney function of young adults. The proportion of adults with this level of impaired kidney function rose from 5.6 percent to 8.0 percent.

The increases in prevalence of chronic kidney disease were largely due to the increases in the prevalence of diabetes, hypertension, and obesity, as well as the aging of the U.S. population. Some of the increase was due to a shift in the mean serum creatinine of the population, which is the blood marker of impaired kidney function.

"Americans and their physicians should be aware that chronic kidney disease is common, has treatable components, and its progression can be slowed substantially. Blood pressure control with agents that protect the kidney, blood sugar control, and avoiding medications toxic to the kidneys are the most important factors for patients with kidney disease to be educated about," said co-author Andrew S. Levy, MD, chief of Nephrology at Tufts-New England Medical Center.
"Prevalence of Chronic Kidney Disease in the United States" was written by Josef Coresh, MD, PhD; Elizabeth Selvin, PhD, MPH; Lesley A. Stevens, MD, MS; Jane Manzi, PhD; John W. Kusek, PhD; Paul Eggers, PhD; Frederick Van Lente, PhD; and Andrew S. Levey, MD.

Funding for the research was provided by grants from the National Institute of Diabetes and Digestive and Kidney Diseases.

Johns Hopkins University Bloomberg School of Public Health

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to